Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice

British Journal of Cancer

Volumn 91, Issue 7, 2004, Pages 1372-1379

  Jamerson, M H ^a   Johnson, M D ^a   Korsmeyer, S J ^b   Furth, P A ^a   Dickson, R B ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Apoptosis; Bax; c Myc; Mammary gland; Transgenic mice; Tumorigenesis

Indexed keywords

PROTEIN BAX; BAX PROTEIN, HUMAN; BAX PROTEIN, MOUSE; MEMBRANE PROTEIN; MTVR2 PROTEIN, MOUSE; ONCOPROTEIN; PROTEIN BCL 2; VIRUS RECEPTOR;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; GENETIC REGULATION; HAPLOIDY; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN FAMILY; PROTO ONCOGENE; REGULATOR GENE; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; CELL DIVISION; DISEASE MODEL; DOWN REGULATION; EXPERIMENTAL NEOPLASM; GENETICS; HUMAN; MOUSE MUTANT; ONCOGENE MYC; PATHOPHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENES, MYC; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, VIRUS;

EID: 6944235079     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602137     Document Type: Article

References (71)

1. Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB (1995) Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Diff 6: 737-748
2. Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, Dickson RB (1996) Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. Oncogene 13: 757-765
3. Antonsson B, Conti F, Ciavetti A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod JJ, Mazzei G, Maundrell K, Gambale F, Sadoul R, Martinou JC (1997) Inhibition of Bax channel-forming activity by Bcl-2. Science 277: 370-372
4. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC (2000) Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 345: 271-278
5. Bargou RC, Daniel PT, Mapara MY, Bommert K, Wagener C, Kallinich B, Royer HD, Dörken B (1995) Expression of the Bcl-2 gene family in normal and malignant breast tissue: low Bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 60: 854-859
6. Bargou RC, Wagener C, Bommert K, Mapara MY, Daniel PT, Arnold W, Dietel M, Guski H, Feller A, Royer HD, Dörken B (1996) Overexpression of the death-promoting gene Bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J Clin Invest 97: 2651-2659
7. Bates SE, Valverius EM, Ennis BW, Bronzert DA, Sheridan JP, Stampfer MR, Mendelsohn J, Lippman ME, Dickson RB (1990) Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinology 126: 596-607
8. Betzl G, Brem G, Weidle UH (1996) Epigenetic modification of transgenes under the control of the mouse mammary tumor virus LTR: tissue-dependent influence on transcription of the transgenes. Biol Chem 377: 711-719
9. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Wakefield LM, Ward JM, Green JE (2000) The mammary pathology of genetically engineered mice: the Consensus report and recommendations from the Annapolis meeting. Oncogene 19: 968-988
10. D'Cruz CM, Gunther DJ, Boxer RB, Hartman JL, Sintasath L, Moody SE, Cox JD, Ha SI, Belka GK, Golant A, Cardiff RD, Chodosh LA (2001) c-Myc induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 7: 235-239
11. Dang CV (1999) c-Myc target genes involved in cell growth, apoptosis and metabolism. Mol Cell Biol 19: 1-11
12. Deming SL, Nass SJ, Dickson RB, Trock BJ (2000) c-Myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer 83: 1688-1695
13. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B, Martinou JC (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144: 891-901
14. Eischen CM, Rehg JE, Korsmeyer SJ, Cleveland JL (2002) Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice. Cancer Res 62: 2184-2191
15. Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL (2001a) Bax loss impairs c-Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol Cell Biol 22: 7653-7662
16. Eischen CM, Woo D, Roussel MF, Cleveland JL (2001b) Apoptosis triggered by Myc-induced suppression of Bcl-xL or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol 21: 5063-5070
17. Elson A, Deng C, Campos-Torres J, Donchower LA, Leder P (1995) The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene 11: 181-190
18. Evan GI, Littlewood TD (1993) The role of c-Myc in cell growth. Curr Opin Genet Dev 3: 44-49
19. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-Myc protein. Cell 69: 119-128
20. Felsher DW, Bishop JM (1999a) Transient excess of Myc activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci USA 96: 3940-3944
21. Felsher DW, Bishop JM (1999b) Reversible tumorigenesis by Myc in hematopoietic lineages. Mol Cell 4: 199-207
22. Feuerhake F, Sigg W, Höfter EA, Dimpfl T, Welsch U (2000) Immunohistochemical analysis of Bcl-2 and Bax expression in relation to cell turnover and epithelial differentiation markers in the non-lactating human mammary gland epithelium. Cell Tissue Res 299: 47-58
23. Griep AE, Krawcek J, Lee D, Liem A, Albert DM, Carabeo R, Drinkwater N, McCall M, Sattler C, Lasudry JG, Lambert PF (1998) Multiple genetic loci modify risk for retinoblastoma in transgenic mice. Invest Ophthalmol Vis Sci 39: 2723-2732
24. Harrington EA, Bennett MR, Fanidi A, Evan GI (1994) c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13: 3286-3295
25. Jäger R, Herzer U, Schenkel J, Weiher H (1997) Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene 15: 1787-1795
26. Jamerson MH, Johnson MD, Dickson RB (2000) Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models. Oncogene 19: 1065-1071
27. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT (1990) TGF-alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61: 1137-1146
28. Juin P, Hueber AO, Littlewood T, Evan GI (1999) c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev 13: 1367-1381
29. Juin P, Hunt A, Littlewood T, Griffiths B, Swigart LB, Korsmeyer SJ, Evan GI (2002) c-Myc functionally cooperates with Bax to induce apoptosis. Mol Cell Biol 22: 6158-6169
30. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC (1998) Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95: 4997-5002
31. Kapranos N, Karaiosifidi H, Valavanis C, Kouri E, Vasilaros S (1997) Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients. Anticancer Res 17: 2499-2506
32. Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ, Korsmeyer SJ (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270: 96-99
33. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S, Reed JC (1995) Bcl-2 family proteins and the regulation of programmed cell death in leukemia and lymphoma. Cancer Res 55: 4471-4478
34. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC (1994) Immunohistochemical determination of the in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145: 1323-1336
35. Le Voyer T, Lu Z, Babb J, Lifsted T, Williams M, Hunter KW (2000) An epistatic interaction controls the latency of a transgene-induced mammary tumor. Mamm Genome 11: 883-889
36. Leder A, Pattengale PK, Kuo A, Stewart TA, Leder P (1986) Consequences of widespread deregulation of the c-Myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45: 485-495
37. Li M, Hu J, Heermeier K, Hennighausen L, Furth PA (1996) Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. Cell Growth Diff 7: 13-20
38. Lifsted T, Le Voyer T, Williams M, Muller W, Klein-Szanto A, Buetow KH, Hunter KW (1998) Dentification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 77: 640-644
39. Mangues R, Schwartz S, Seidman I, Pellicer A (1995) Promoter demethylation in MMTV/N-ras transgenic mice required for transgene expression and tumorigenesis. Mol Carcinogen 14: 94-102
40. Matsui Y, Halter SA, Holt JT, Hogan BLM, Coffey RJ (1990) Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell 61: 1147-1155
41. McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB (1998) Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis, and chromosal instability. Oncogene 16: 2755-2766
42. Mitchell KO, Ricci MS, Miyashita T, Dicker DT, Jin Z, Reed JC, El-Deiry WS (2000) Bax is a transcriptional target and mediator of c-Myc-induced apoptosis. Cancer Res 60: 6318-6325
43. Murphy KM, Streips UN, Lock RB (1999) Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2. Oncogene 18: 5991-5999
44. Nass SJ, Dickson RB (1997) Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res Treat 44: 1-22
45. Nouraini S, Six E, Matsuyama S, Krajewski S, Reed JC (2000) The putative pore-forming domain of Bax regulates mitochondrial localization and interaction with Bcl-xL. Mol Cell Biol 20: 1604-1615
46. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619
47. Packham G, Cleveland JL (1995) c-Myc and apoptosis. Biochim Biophys Acta 1242: 11-28
48. Prendergast GC (1999) Mechanisms of apoptosis by c-Myc. Oncogene 18: 2967-2987
49. Rose-Hellekant TA, Gilchrist K, Sandgren EP (2002) Strain background alters mammary gland lesion phenotype in transforming growth factor-a transgenic mice. Am J Pathol 161: 1439-1447
50. Rowse GJ, Ritland SR, Gendler SJ (1998) Genetic modulation of neu protooncogene-induced mammary tumorigenesis. Cancer Res 58: 2675-2679
51. Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, Nakatani H, Tsujimoto H, Imanishi T, Ohgaki M, Ohyama T, Yamazaki J, Hagiwara A, Yamaguchi T, Sawai K, Takahashi T (1996) Overexpression of Bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer 67: 101-105
52. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC (1990) Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61: 1121-1135
53. Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL, Lee DC (1995) Inhibition of mammary gland involution associated with transforming growth factor α but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res 55: 3915-3927
54. Santoni-Rugiu E, Jensen MR, Thorgeirsson SS (1998) Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-Myc and transforming growth factor alpha. Cancer Res 58: 123-134
55. Schorr K, Li M, Bar-Peled U, Lewis A, Heredia A, Lewis B, Knudson CM, Korsmeyer SJ, Jäger R, Weiher H, Furth PA (1999a) Gain of Bcl-2 is more potent than Bax loss in regulating mammary epithelial cell survival in vivo. Cancer Res 59: 2541-2545
56. Schorr K, Li M, Krajewski S, Reed JC, Furth PA (1999b) Bcl-2 gene family and related proteins in mammary gland involution and breast cancer. J Mamm Gland Biol Neoplasia 4: 153-164
57. Shibata MA, Liu ML, Knudson MC, Shibata E, Yoshidome K, Bandey T, Korsmeyer SJ, Green JE (1999) Haploid loss of Bax leads to accelerated mammary tumor development in C3(1)/SV40-Tag transgenic mice: reduction in protective apoptotic response at the preneoplastic stage. EMBO J 18: 2692-2701
58. Shilkaitis A, Graves J, Mehta RR, Hu L, You M, Lubet R, Steele V, Kelloff G, Christov K (2000) Bcl-2 and bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis. Cell Growth Diff 11: 437-445
59. Sjöström J, Krajewski S, Franssila K, Niskanen E, Wasenius VM, Nordling S, Reed JC, Blomqvist C (1998) A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer. Br J Cancer 78: 812-815
60. Snedeker SM, Brown CF, DiAugustine RP (1991) Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci USA 88: 276-280
61. Soucie EL, Annis MG, Sedivy J, Filmus J, Leber B, Andrews DW, Penn LZ (2001) Myc potentiates apoptosis by stimulating Bax activity at the mitochondria. Mol Cell Biol 21: 4725-4736
62. Stewart TA, Pattengale PK, Leder P (1984) Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38: 627-637
63. Strange R, Li F, Saurer S, Burkhardt A, Friis RR (1992) Apoptotic cell death and tissue remodeling during mouse mammary gland involution. Development 115: 49-58
64. Telang NT, Osborne MP, Sweterlitsch LA, Narayanan R (1990) Neoplastic transformation of mouse mammary epithelial cells by deregulated Myc expression. Cell Regul 1: 863-872
65. Valverius EM, Ciardiello F, Heldin NE, Blondel B, Merlo G, Smith GH, Stampfer MR, Lippman ME, Dickson RB, Salomon DS (1990) Stromal influences on transformation of human mammary epithelial cells overexpressing c-Myc and SV40T. J Cell Physiol 145: 207-216
66. Vennstrom B, Sheiness D, Zabielski J, Bishop JM (1982) Isolation and characterization of c-Myc, a cellular homolog of the oncogene (v-Myc) of avian myelocytomatosis virus strain 29. J Virol 42: 773-779
67. Weaver ZA, McCormack SJ, Liyanage M, du Manoir S, Coleman A, Schröck E, Dickson RB, Ried T (1999) A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-c-myc transgenic mice. Genes Chromosome Cancer 25: 251-260
68. Wei MC, Zong WX, Cheng EHY, Lindsten T, Panousakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730
69. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). Br J Cancer 77: 1-10
70. Zhou H, Chen W, Qin X, Lee K, Liu L, Markowitz SD, Gerson SL (2001) MMTV promoter hypomethylation is linked to spontaneous and MNU-associated c-neu expression and mammary carcinogenesis in MMTV-c-neu transgenic mice. Oncogene 20: 6009-6017
71. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 12: 2424-2433